Holen Sie sich die Stockscreener-App
3.55
3.80%
0.13
Schlusskurs vom Vortag:
$3.42
Offen:
$3.66
24-Stunden-Volumen:
71,864
Relative Volume:
0.55
Marktkapitalisierung:
$38.34M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-19.25M
KGV:
-1.9944
EPS:
-1.78
Netto-Cashflow:
$-17.87M
1W Leistung:
-7.07%
1M Leistung:
-18.20%
6M Leistung:
-10.80%
1J Leistung:
-7.55%
1-Tages-Spanne:
$3.50
$3.69
1-Wochen-Bereich:
$3.02
$3.905
52-Wochen-Spanne:
$2.55
$6.118
Lantern Pharma Inc Stock (LTRN) Company Profile
Firmenname
Lantern Pharma Inc
Sektor
Branche
Telefon
972-277-1136
Adresse
1920 MCKINNEY AVENUE, DALLAS, TX
Vergleichen Sie LTRN mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
LTRN
Lantern Pharma Inc
|
3.55 | 36.93M | 0 | -19.25M | -17.87M | -1.78 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Lantern Pharma Inc Stock (LTRN) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2021-10-07 | Eingeleitet | H.C. Wainwright | Buy |
Lantern Pharma Inc Aktie (LTRN) Neueste Nachrichten
How Lantern Pharma Inc. stock performs in weak economyJuly 2025 Analyst Calls & Low Volatility Stock Suggestions - newser.com
Lantern Pharma Engages New to The Street for National Media Coverage Featuring Television, Press, Earned Media and Non-Deal Investor Focused Roadshows - Florida Today
Lantern Pharma (NASDAQ: LTRN) CEO Discusses AI-Driven Cancer Drug Development in FintechTV Interview at NYSE - Digital Journal
Can Lantern Pharma Inc. stock deliver consistent earnings growthJuly 2025 WrapUp & Long-Term Safe Return Strategies - newser.com
Lantern Pharma Inc. stock trendline breakdownEarnings Summary Report & Community Trade Idea Sharing - newser.com
Is Lantern Pharma Inc. stock attractive for income investorsWatch List & Stepwise Trade Signal Guides - newser.com
Enlivex Therapeutics and Lantern Pharma Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV - Lancaster Eagle-Gazette
Lantern Pharma (LTRN) Partners with New to The Street for Extens - GuruFocus
When is the best time to exit Lantern Pharma Inc.Trade Ideas & AI Optimized Trading Strategy Guides - newser.com
Lantern Pharma (NASDAQ: LTRN) Sets Nov. 13 Webcast to Review Q3 2025 Results and AI Platform Developments - The Globe and Mail
Lantern Pharma to Report Third Quarter 2025 Operating & Financial Results on November 13th, 2025 at 9:00 a.m. ET - BioSpace
Album 9, Track 9: Steady On – Lantern Pharma (Podcast)HealthcareUnited States - Mondaq
How Lantern Pharma Inc. stock reacts to oil pricesJuly 2025 Pullbacks & Daily Volume Surge Trade Alerts - newser.com
Why Lantern Pharma Inc. stock is favored by pension fundsBuy Signal & Momentum Based Trading Ideas - newser.com
Is Lantern Pharma Inc. stock a buy before product launchesMarket Weekly Review & Growth Focused Investment Plans - newser.com
Full technical analysis of Lantern Pharma Inc. stockTrade Analysis Summary & Reliable Price Breakout Alerts - newser.com
Using economic indicators to assess Lantern Pharma Inc. potentialGap Down & Fast Moving Stock Watchlists - newser.com
Will Lantern Pharma Inc. stock recover after recent drop2025 Historical Comparison & Stock Portfolio Risk Management - newser.com
How to interpret RSI for Lantern Pharma Inc. stockMarket Trend Summary & Fast Gain Swing Alerts - newser.com
Lantern Pharma Inc. (LTRN) Analyst Insights, Price Targets & Recommendations - Yahoo! Finance Canada
Will Lantern Pharma Inc. stock maintain dividend yieldQuarterly Trade Review & Breakout Confirmation Trade Signals - newser.com
Lantern Pharma : Corporate Overview - MarketScreener
Lantern Pharma Inc. (NASDAQ:LTRN) Q3 2024 Earnings Call Transcript - MSN
What drives Lantern Pharma Inc stock priceEvening Star Patterns & Big Gains Small Budget - earlytimes.in
Lantern Pharma Inc. (LTRN) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
Finanzdaten der Lantern Pharma Inc-Aktie (LTRN)
Umsatz
Nettogewinn
Free Cashflow
ENV
Lantern Pharma Inc-Aktie (LTRN) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kreis Leslie W. | 10% Owner |
Jun 13 '25 |
Sale |
3.09 |
40,000 |
123,600 |
49,957 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Fletcher Aaron G.L. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Kreis Leslie W. | 10% Owner |
Jun 12 '25 |
Sale |
3.38 |
60,647 |
204,987 |
51,860 |
| Kreis Leslie W. | 10% Owner |
Jun 11 '25 |
Sale |
3.40 |
950 |
3,230 |
54,746 |
| Kreis Leslie W. | 10% Owner |
Jun 10 '25 |
Sale |
3.40 |
16 |
54 |
54,791 |
| Fletcher Aaron G.L. | 10% Owner |
May 27 '25 |
Sale |
3.05 |
21,037 |
64,163 |
56,467 |
| Fletcher Aaron G.L. | 10% Owner |
May 29 '25 |
Sale |
3.03 |
20,200 |
61,206 |
54,792 |
| Fletcher Aaron G.L. | 10% Owner |
May 28 '25 |
Sale |
2.87 |
15,000 |
43,050 |
55,753 |
0.05%
1.40%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):